Sonic Incytes is redefining the standard of care in quantifying liver stiffness and attenuation. Recognizing the rise of fatty liver disease, we’ve made it our mission to make liver health a new vital sign. Our novel, portable, handheld solution assesses liver attenuation with ultrasound, and liver stiffness with technology similar to that of MRI elastography, the current non-invasive gold standard. Velacur aids in the clinical management of patients with liver disease, with measurements you can count on. Founded in 2017, Sonic Incytes Medical Corp. is a medical device company headquartered in Vancouver, Canada. We’ve cultivated strong partnerships for the benefit of patients worldwide.